Literature DB >> 18562180

Dynamic frequency of CD4+CD25+Foxp3+ Treg cells in psoriasis vulgaris.

Ling Chen, Zhu Shen, Gang Wang, Pingshen Fan, Yufeng Liu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18562180     DOI： 10.1016/j.jdermsci.2008.04.015

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  8 in total

Review 1.  Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.

Authors:  Jane Hoyt Buckner
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

2.  Etanercept downregulates the Th17 pathway and decreases the IL-17+/IL-10+ cell ratio in patients with psoriasis vulgaris.

Authors:  Emiliano Antiga; Walter Volpi; Elisa Cardilicchia; Laura Maggi; Lucia Filì; Cinzia Manuelli; Paola Parronchi; Paolo Fabbri; Marzia Caproni
Journal:  J Clin Immunol       Date:  2012-06-15       Impact factor: 8.317

3.  miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.

Authors:  Maryam Ahmadian-Elmi; Ali Bidmeshki Pour; Reza Naghavian; Kamran Ghaedi; Somayeh Tanhaei; Tayebeh Izadi; Mohammad Hossein Nasr-Esfahani
Journal:  Immunogenetics       Date:  2015-11-13       Impact factor: 2.846

4.  Immunophenotype lymphocyte of peripheral blood in patients with psoriasis.

Authors:  Jasenko Karamehic; Lamija Zecevic; Halima Resic; Majda Jukic; Tomislav Jukic; Ognjen Ridjic; Mirsad Panjeta; Jozo Coric
Journal:  Med Arch       Date:  2014-07-31

Review 5.  The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.

Authors:  Bogusław Nedoszytko; Magdalena Lange; Małgorzata Sokołowska-Wojdyło; Joanna Renke; Piotr Trzonkowski; Michał Sobjanek; Aneta Szczerkowska-Dobosz; Marek Niedoszytko; Aleksandra Górska; Jan Romantowski; Justyna Czarny; Jarosław Skokowski; Leszek Kalinowski; Roman Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

6.  Expression of miR-135b in Psoriatic Skin and Its Association with Disease Improvement.

Authors:  Pablo Chicharro; Pedro Rodríguez-Jiménez; Mar Llamas-Velasco; Nuria Montes; Ancor Sanz-García; Danay Cibrian; Alicia Vara; Manuel J Gómez; María Jiménez-Fernández; Pedro Martínez-Fleta; Inés Sánchez-García; Marta Lozano-Prieto; Juan C Triviño; Rebeca Miñambres; Francisco Sánchez-Madrid; Hortensia de la Fuente; Esteban Dauden
Journal:  Cells       Date:  2020-07-02       Impact factor: 6.600

7.  Molecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes but Different Regulatory Gene Sets.

Authors:  Jaehwan Kim; Chil-Hwan Oh; Jiehyun Jeon; Yoosang Baek; Jaewoo Ahn; Dong Joo Kim; Hyun-Soo Lee; Joel Correa da Rosa; Mayte Suárez-Fariñas; Michelle A Lowes; James G Krueger
Journal:  J Invest Dermatol       Date:  2016-01       Impact factor: 8.551

Review 8.  Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances.

Authors:  Dominik Samotij; Bogusław Nedoszytko; Joanna Bartosińska; Aleksandra Batycka-Baran; Rafał Czajkowski; Iwona T Dobrucki; Lawrence W Dobrucki; Magdalena Górecka-Sokołowska; Anna Janaszak-Jasienicka; Dorota Krasowska; Leszek Kalinowski; Marta Macieja-Stawczyk; Roman J Nowicki; Agnieszka Owczarczyk-Saczonek; Agata Płoska; Dorota Purzycka-Bohdan; Adrianna Radulska; Edyta Reszka; Anna Siekierzycka; Andrzej Słomiński; Radomir Słomiński; Marta Sobalska-Kwapis; Dominik Strapagiel; Aneta Szczerkowska-Dobosz; Justyna Szczęch; Michał Żmijewski; Adam Reich
Journal:  Postepy Dermatol Alergol       Date:  2020-05-05       Impact factor: 1.837
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.